John M. Evans, CEO at Beam Therapeutics Inc. (BEAM), sold 35,071 shares at $83.76 ($3.0M) on 2020-12-30, disclosed to the SEC on 2021-01-04.
Open-market sale of $3.0M BEAM by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.14 | 1,366 | $111K | 3.7% |
| 2 | $81.14 | 1,366 | $111K | 3.7% |
| 3 | $82.33 | 4,100 | $338K | 11.3% |
| 4 | $83.76 | 4,925 | $413K | 13.8% |
| 5 | $85.35 | 1,422 | $121K | 4.1% |
| 6 | $85.35 | 1,422 |
| $121K |
| 4.1% |
| 7 | $86.21 | 7,196 | $620K | 20.7% |
| 8 | $86.21 | 7,196 | $620K | 20.7% |
| 9 | $86.79 | 504 | $44K | 1.5% |
| 10 | $88.12 | 1,121 | $99K | 3.3% |
| 11 | $88.12 | 1,121 | $99K | 3.3% |
| 12 | $89.41 | 1,666 | $149K | 5.0% |
| 13 | $89.41 | 1,666 | $149K | 5.0% |
| Total | $85.38 avg | 35,071 | $3.0M | 100% |
| Filing → |
| BEAM | SELL | 2026-04-01 | $1.1M | — | Filing → |
| BEAM | SELL | 2026-02-02 | $2.8M | — | Filing → |
| BEAM | SELL | 2025-10-03 | $1.2M | — | Filing → |